Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from Tourmaline Bio (TRML) is now available.
Tourmaline Bio, Inc. has promoted Ryan Robinson to Chief Financial Officer and Treasurer, a step up from his prior role as Interim CFO. As of June 25, 2024, his new compensation includes a $445,000 base salary, with potential annual cash incentives up to 40% of that salary. Robinson was also granted an option to purchase 76,400 shares of the company’s stock, vesting over four years subject to continuous service. Additionally, he’s covered by an Executive Severance and Change in Control Plan, ensuring a lump sum payment in case of death or disability. Robinson’s appointment is based solely on his merits, without any disclosed familial or financial conflicts of interest.
For detailed information about TRML stock, go to TipRanks’ Stock Analysis page.
